• 8603 Citations
  • 37 h-Index
1987 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Outputs

2008

Dose calculation of anticancer drugs

Gao, B., Klumpen, H. J. & Gurney, H., Oct 2008, In : Expert Opinion on Drug Metabolism and Toxicology. 4, 10, p. 1307-1319 13 p.

Research output: Contribution to journalReview article

30 Citations (Scopus)

Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?

Chang, D. K., Merrett, N. D., Biankin, A. V. & NSW Pancreatic Cancer Network, Jul 2008, In : Journal of Gastroenterology and Hepatology (Australia). 23, 7 Pt 1, p. 1036-45 10 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)
13 Citations (Scopus)

Multinodular goitre: An unusual cause in a patient with acromegaly

Wong, V. W., Gurney, H. & Hazel, J. R., Sep 2008, In : Internal Medicine Journal. 38, 9, p. 742-743 2 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand

Bell, D., Grimes, D., Gurney, H., Dalley, D., Blackwell, T., Fox, R. & Jeffery, M., Oct 2008, In : Internal Medicine Journal. 38, 10, p. 751-757 7 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Transporter pumps and imatinib: A cause of pharmacokinetic resistance?

Klumpen, H. J., Liddle, C. & Gurney, H., Mar 2008, In : Cancer Biology and Therapy. 7, 3, p. 416-418 3 p.

Research output: Contribution to journalComment/opinion

1 Citation (Scopus)
2007

Allogeneic bone marrow transplant for refractory mediastinal germ cell tumour: Possible evidence of graft-versus-tumour effect

Goodwin, A., Gurney, H. & Gottlieb, D., Feb 2007, In : Internal Medicine Journal. 37, 2, p. 127-129 3 p.

Research output: Contribution to journalReview article

2 Citations (Scopus)

Death of a clinical trial: A speculative inclusion criterion gone wrong [3]

Rosenthal, M. A., Woo, H., Gurney, H., Copeman, M. & Zingarelli, G., Dec 2007, In : Internal Medicine Journal. 37, 12, p. 838-839 2 p.

Research output: Contribution to journalLetter

Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype

Gurney, H., Wong, M., Balleine, R. L., Rivory, L. P., McLachlan, A. J., Hoskins, J. M., Wilcken, N., Clarke, C. L., Mann, G. J., Collins, M., Delforce, S. E., Lynch, K. & Schran, H., 14 Jul 2007, In : Clinical Pharmacology and Therapeutics. 82, 1, p. 33-40 8 p.

Research output: Contribution to journalArticle

114 Citations (Scopus)

Obesity in dose calculation: A mouse or an elephant?

Gurney, H. & Shaw, R., 20 Oct 2007, In : Journal of Clinical Oncology. 25, 30, p. 4703-4704 2 p.

Research output: Contribution to journalEditorial

12 Citations (Scopus)

Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management

Desai, J., Gurney, H., Pavlakis, N., Mcarthur, G. A. & Davis, I. D., Dec 2007, In : Asia-Pacific Journal of Clinical Oncology. 3, 4, p. 167-176 10 p.

Research output: Contribution to journalReview article

12 Citations (Scopus)
2006

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., Corica, T., Korbel, E., Weinstein, S. & McCaul, K., May 2006, In : European Journal of Cancer. 42, 8, p. 1083-1092 10 p.

Research output: Contribution to journalArticle

91 Citations (Scopus)

Developing a new framework for dose calculation

Gurney, H., 1 Apr 2006, In : Journal of Clinical Oncology. 24, 10, p. 1489-1490 2 p.

Research output: Contribution to journalEditorial

18 Citations (Scopus)

Maintaining bone health in patients with prostate cancer

Holmes-Walker, J., Woo, H., Gurney, H., Do, V. T. & Chipps, D. R., 20 Feb 2006, In : Medical Journal of Australia. 184, 4, p. 176-179 4 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer

Wong, M., Balleine, R. L., Blair, E. Y. L., McLachlan, A. J., Ackland, S. P., Garg, M. B., Evans, S., Farlow, D., Collins, M., Rivory, L. P., Hoskins, J. M., Mann, G. J., Clarke, C. L. & Gurney, H., 1 Jun 2006, In : Journal of Clinical Oncology. 24, 16, p. 2448-2455 8 p.

Research output: Contribution to journalArticle

49 Citations (Scopus)
2005

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer

Wong, M., Evans, S., Rivory, L. P., Hoskins, J. M., Mann, G. J., Farlow, D., Clarke, C. L., Balleine, R. L. & Gurney, H., Jan 2005, In : Clinical Pharmacology and Therapeutics. 77, 1, p. 33-42 10 p.

Research output: Contribution to journalArticle

56 Citations (Scopus)

I don't underdose my patients...do I? [3]

Gurney, H., Sep 2005, In : Lancet Oncology. 6, 9, p. 637-638 2 p.

Research output: Contribution to journalLetter

19 Citations (Scopus)
2004

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy

Wong, M., Balleine, R. L., Collins, M., Liddle, C., Clarke, C. L. & Gurney, H., Jun 2004, In : Clinical Pharmacology and Therapeutics. 75, 6, p. 529-538 10 p.

Research output: Contribution to journalArticle

76 Citations (Scopus)
2002

How to calculate the dose of chemotherapy

Gurney, H., 22 Apr 2002, In : British Journal of Cancer. 86, 8, p. 1297-1302 6 p.

Research output: Contribution to journalArticle

155 Citations (Scopus)

Phase II trial of branched peginterferon-α 2a (40 kDa) for patients with advanced renal cell carcinoma

Motzer, R. J., Rakhit, A., Thompson, J., Gurney, H., Selby, P., Figlin, R., Negrier, S., Ernst, S., Siebels, M., Ginsberg, M., Rittweger, K. & Hooftman, L., 1 Nov 2002, In : Annals of Oncology. 13, 11, p. 1799-1805 7 p.

Research output: Contribution to journalArticle

47 Citations (Scopus)

α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma

Wong, M., Goldstein, D., Woo, H., Testa, G. & Gurney, H., 2002, In : Internal Medicine Journal. 32, 4, p. 158-162 5 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)
2001

Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features

Shannon, C., Crombie, C., Brooks, A., Lau, H., Drummond, M. & Gurney, H., 2001, In : Annals of Oncology. 12, 7, p. 947-952 6 p.

Research output: Contribution to journalArticle

45 Citations (Scopus)
2000

A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Rischin, D., Smith, J., Millward, M., Lewis, C., Boyer, M., Richardson, G., Toner, G., Gurney, H. & McKendrick, J., 2000, In : British Journal of Cancer. 83, 4, p. 438-442 5 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy

King, M. T., Hall, J., Caleo, S., Gurney, H. P. & Harnett, P. R., 2000, In : International Journal of Health Services. 30, 3, p. 557-579 23 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)
1999

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer

Bishop, J. F., Dewar, J., Toner, G. C., Smith, J., Tattersall, M. H. N., Olver, I. N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J., Stephenson, J. & Canetta, R., Aug 1999, In : Journal of Clinical Oncology. 17, 8, p. 2355-2364 10 p.

Research output: Contribution to journalArticle

184 Citations (Scopus)

Long-term follow-up of patients treated with intermittent hormone therapy for advanced prostate cancer

Hruby, G., Gurney, H., Turner, S., Berry, M., Harnett, P. & Gebski, V., May 1999, In : Prostate Journal. 1, 3, p. 138-143 6 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
1998

Factors affecting epirubicin pharmacokinetics and toxicity: Evidence against using body-surface area for dose calculation

Gurney, H. P., Ackland, S., Gebski, V. & Farrell, G., Jul 1998, In : Journal of Clinical Oncology. 16, 7, p. 2299-2304 6 p.

Research output: Contribution to journalArticle

100 Citations (Scopus)
6 Citations (Scopus)

Skull metastases masquerading as cerebral secondaries in patients with cancer

Wright, J., Gurney, H. & Glare, P., 1998, In : Australian and New Zealand Journal of Medicine. 28, 1, p. 62 1 p.

Research output: Contribution to journalArticle

1997

A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results

Bishop, J. F., Dewar, J., Toner, G., Tattersall, M. H., Olver, I., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J. & Stephenson, J., 1997, In : Seminars in Oncology. 24, 5 SUPPL. 17, p. S17-5-S17-9 5 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Paclitaxel as first-line treatment for metastatic breast cancer

Bishop, J. F., Dewar, J., Toner, G. C., Tattersall, M. H., Olver, I. N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J. & Stephenson, J., 1997, In : ONCOLOGY. 11, 4 SUPPL. 3, p. 19-23 5 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)
1996

Dose calculation of anticancer drugs: A review of the current practice and introduction of an alternative

Gurney, H., 1996, In : Journal of Clinical Oncology. 14, 9, p. 2590-2611 22 p.

Research output: Contribution to journalReview article

291 Citations (Scopus)
1995

Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer

Gurney, H., Harnett, P., Stuart-Harris, R. & Kefford, R., 1995, In : European Journal of Cancer. 31, 11, p. 1773-1777 5 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
1993

A cost-utility approach to the use of 5-fluorouracil and levamisole ad adjuvant chemotherapy for Dukes' C colonic carcinoma

Smith, R. D., Hall, J., Gurney, H. & Harnett, P. R., 1993, In : Medical Journal of Australia. 158, 5, p. 319-320 2 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)

A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma [5]

De Souza, P., Smith, R. D., Hall, J., Gurney, H. & Harnett, P. R., 1993, In : Medical Journal of Australia. 158, 12, p. 866 1 p.

Research output: Contribution to journalLetter

A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for dukes c-colonic carcinoma - Reply

Smith, RD., Hall, J., Gurney, H. & Harnett, PR., 21 Jun 1993, In : Medical Journal of Australia. 158, 12, p. 866-866 1 p.

Research output: Contribution to journalLetter

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice -part 2

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Feb 1993, In : Annals of Oncology. 4, 2, p. 103-115 13 p.

Research output: Contribution to journalReview article

36 Citations (Scopus)

Escalating drug delivery in cancer chemotherapy: A review of concepts and practice - part 1

Gurney, H., Dodwell, D., Thatcher, N. & Tattersall, M. H. N., Jan 1993, In : Annals of Oncology. 4, 1, p. 23-34 12 p.

Research output: Contribution to journalReview article

35 Citations (Scopus)

Hypercalcaemia in small cell lung cancer: Report of a case associated with parathyroid hormone-related protein (PTHrP)

Stuart-Harris, R., Ahern, V., Danks, J. A., Gurney, H. & Martin, T. J., 1993, In : European Journal of Cancer. 29, 11, p. 1601-1604 4 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia

Gurney, H., Grill, V. & Martin, T. J., 26 Jun 1993, In : The Lancet. 341, 8861, p. 1611-1613 3 p.

Research output: Contribution to journalArticle

91 Citations (Scopus)
1992

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Pettengell, R., Gurney, H., Radford, J. A., Deakin, D. P., James, R., Wilkinson, P. M., Kane, K., Bentley, J. & Crowther, D., 1992, In : Blood. 80, 6, p. 1430-1436 7 p.

Research output: Contribution to journalArticle

373 Citations (Scopus)

Haemopoietic cell kinetics in humans treated with rGM‐CSF

Lord, B. I., Gurney, H., Chang, J., Thatcher, N., Crowther, D. & Dexter, T. M., 1992, In : International Journal of Cancer. 50, 1, p. 26-31 6 p.

Research output: Contribution to journalArticle

62 Citations (Scopus)

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

Gurney, H., Anderson, H., Radford, J., Potter, M. R., Swindell, R., Steward, W., Kamthan, A., Chang, J., Weiner, J., Thatcher, N. & Crowther, D., 1992, In : European Journal of Cancer. 28, 1, p. 105-112 8 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)
1991

A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer

Lind, M. J., Gomm, S., Simmonds, A. P., Ashcroft, L., Kamthan, A., Gurney, H. & Thatcher, N., Mar 1991, In : Cancer Chemotherapy and Pharmacology. 28, 2, p. 142-144 3 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer

Gurney, H., de Campos, E. S., Dodwell, D., Kamthan, A. & Thatcher, N., 1991, In : European Journal of Cancer and Clinical Oncology. 27, 5, p. 565-567 3 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

Recombinant human GM-CSF in small cell lung cancer: a phase I/II study.

Anderson, H., Gurney, H., Thatcher, N., Swindell, R., Scarffe, J. H. & Weiner, J., 1991, Supportive Care in Cancer Patients II. SENN, HJ. & GLAUS, A. (eds.). Berlin; Heidelberg: Springer, Springer Nature, Vol. 121. p. 155-161 7 p. (RECENT RESULTS IN CANCER RESEARCH; vol. 121).

Research output: Chapter in Book/Report/Conference proceedingConference proceeding contribution

4 Citations (Scopus)

The use of L-dopa and carbidopa in metastatic malignant melanoma

Gurney, H., Coates, A. & Kefford, R., Jan 1991, In : Journal of Investigative Dermatology. 96, 1, p. 85-87 3 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)
1990

A phase-I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving intensive chemotherapy for small-cell lung-cancer

Anderson, H., Gurney, H., Radford, J., Steward, WP., Kamthan, A., Chang, J. & Thatcher, N., Sep 1990, In : British Journal of Cancer. 62, 3, p. 528-528 1 p.

Research output: Contribution to journalMeeting abstract

202 Citations (Scopus)

A phase-II study of ifosfamide and alpha-2 interferon (intron-A) in advanced non-small cell lung-cancer

Lind, MJ., Thatcher, N., Gurney, H. & Kamthan, A., Sep 1990, In : British Journal of Cancer. 62, 3, p. 502-502 1 p.

Research output: Contribution to journalMeeting abstract

Dose intensity in cancer chemotherapy

Dodwell, D. J., Gurney, H. & Thatcher, N., 1990, In : British Journal of Cancer. 61, 6, p. 789-794 6 p.

Research output: Contribution to journalEditorial

36 Citations (Scopus)